|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/17 | (2015.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 48/00 | (2013.01) | ||
| A61K 48/00 | (2006.01) | ||
| A61K 31/4245 | (2013.01) | ||
| A61K 35/17 | (2013.01) | ||
| A61K 31/4245 | (2006.01) | ||
| C07K 14/725 | (2006.01) | ||
| C07K 14/7051 | (2013.01) | ||
| C12Q 1/26 | (2006.01) | ||
| C12N 5/0636 | (2013.01) | ||
| C12N 5/0783 | (2010.01) | ||
| G01N 33/57496 | (2013.01) | ||
| G01N 33/574 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| C12N2502/30 | (2013.01) | ||
| C07K 14/705 | (2006.01) | ||
| C12N2510/00 | (2013.01) | ||
| C07K 14/705 | (2013.01) | ||
| C12Y 113/11011 | (2013.01) | ||
| C12Y 113/11052 | (2013.01) | ||
| C12Y 207/11001 | (2013.01) | ||
| C12Y 207/11013 | (2013.01) | ||
| C07K2319/03 | (2013.01) | ||
| C12N2740/16043 | (2013.01) |
| (11) | Number of the document | 3525803 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17801797.6 |
| Date of filing the European patent application | 2017-10-13 | |
| (97) | Date of publication of the European application | 2019-08-21 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/056680 |
| Date | 2017-10-13 |
| (87) | Number | WO 2018/071873 |
| Date | 2018-04-19 |
| (30) | Number | Date | Country code |
| 201662407776 P | 2016-10-13 | US | |
| 201762514767 P | 2017-06-02 | US |
| (72) |
PORTS, Michael , US
THOMAS, Evan Paul , US
LEVITSKY, Hyam I , US
|
| (73) |
Juno Therapeutics, Inc. ,
400 Dexter Avenue North, Suite 1200, Seattle, WA 98109,
US
|
| (54) | IMMUNOTHERAPY METHODS AND COMPOSITIONS INVOLVING TRYPTOPHAN METABOLIC PATHWAY MODULATORS |
| IMMUNOTHERAPY METHODS AND COMPOSITIONS INVOLVING TRYPTOPHAN METABOLIC PATHWAY MODULATORS |